To investigate whether direct tumor recognition by TR-CD4 could bypass the requirement for APCs to enhance the function of CD8+ T cells, ESO-CD8 was co-cultured with SK37 in the presence of TR-CD4 or NTR-CD4. The gene discussed is CD8A; the disease is neoplasm.